Roth Capital reiterated al Buy rating and $3.75 price target on SenesTech (NASDAQ: SNES) as California is set to approve ContraPest which opens a large environmentally focused market, where there is likely a subset of customers focused on the environmental aspects of the Product. After approval, SNES will be allowed to market at trade shows and advertise where appropriate within the state.
Roth Capital updated their estimates to reflect a slower ramp than the original model. 2018 revenue is now $3.1mm and 2019 revenue estimate is $17.5mm. Estimated EBITDA is ($4.4mm) and $4.4mm for 2018 and 2019.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.